Congrats to the UM team awarded $6.9 million by the @CIHR_IRSC to lead an international trial of a steroid drug for pneumonia. The grant will enable expansion of a network of hospital-ward research sites, helping Canada prepare for future pandemics. news.umanitoba.ca/um-team-re…
Today, Minister of Health Mark Holland announced a $43M investment in 14 new Canadian-led #ClinicalTrials to assess treatments and tools with the potential to save lives.
canada.ca/en/institutes-heal…
200 patients enrolled in ATTACC-CAP!!
💯 💯
Thanks to all our patient participants, their families, our sites, investigators, coordinators, and large number of partners!
@ATTACC_CAP
200 patients enrolled in ATTACC-CAP!!
💯 💯
Thanks to all our patient participants, their families, our sites, investigators, coordinators, and large number of partners!
@ATTACC_CAP
We are pleased to announce an investment
of $500K allocated over 5 years designated to support the ATTACC-CAP trail led by @umanitoba researcher @RZarychanski, this will be the second-largest clinical trial led out of Manitoba.
Read full news release: bit.ly/44gf40Q
Honored to be recognized as @DoctorsManitoba top 40 under 40! This represents the efforts of a large research team - through COVID and now beyond…. It’s thanks to a productive and enabling team and mentors that we can innovate in medicine, for the benefits of our patients.
We are pleased to announce an investment
of $500K allocated over 5 years designated to support the ATTACC-CAP trail led by @umanitoba researcher @RZarychanski, this will be the second-largest clinical trial led out of Manitoba.
Read full news release: bit.ly/44gf40Q
ATTACC PI Dr. Ryan Zarychanski is being recognized as Doctors Manitoba Physician of the Year. Congratulations @RZarychanski! We look forward to your leadership in the next chapter of the ATTACC trial.
Physician of the Year, Dr. Ryan Zarychanski is being recognized for his truly groundbreaking work leading world-wide efforts to rapidly identify effective COVID-19 treatments. @RZarychanski
🔥 This week we'll be discussing the hot topic of VTE Prophylaxis in COVID-19
‼️ Our latest protocol is published on Ask Mayo Expert (AME): mayocl.in/35QZcJu
Go to Inpatient management (adult) ➡️ Inpatient care ➡️ COVID-19 VTE Prophylaxis in Hospitalized Patients
Practice changing work from the #mpRCT and efforts of @ACTIV4a @ATTACC_COVID @remap_cap. @nih_nhlbi @NIH guidelines recommending therapeutic heparin for moderately ill hospitalized patients with #Covid_19 based on our @NEJM papers @NIHCOVIDTxGuide @UPMC@PittTweet
Breaking news on #Covid_19 treatment from @nih_nhlbi!
A recommendation for full anticoagulation with low molecular weight heparin for hospitalized patients. Please spread the word!
bit.ly/3n1sZF8
1/2 Breaking from #ASH21 VTE guidelines session: Dr Sanfillipo presents the preliminary recommendation in acutely ill (not critically ill) patients with #COVID19: suggest to use therapeutic LMWH over prophylactic dose LMWH